Meiyanto, E., Husnaa, U., Kastian, R. F., Putri, H., Larasati, Y. A., Khumaira, A., . . . Kato, J. (2021). The Target Differences of Anti-Tumorigenesis Potential of Curcumin and its Analogues Against HER-2 Positive and Triple-Negative Breast Cancer Cells. Adv Pharm Bull.
Citação norma ChicagoMeiyanto, Edy, et al. "The Target Differences of Anti-Tumorigenesis Potential of Curcumin and Its Analogues Against HER-2 Positive and Triple-Negative Breast Cancer Cells." Adv Pharm Bull 2021.
Citação norma MLAMeiyanto, Edy, et al. "The Target Differences of Anti-Tumorigenesis Potential of Curcumin and Its Analogues Against HER-2 Positive and Triple-Negative Breast Cancer Cells." Adv Pharm Bull 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.